about
Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador.Etiology of chronic urticaria: the Ecuadorian experience.Management of chronic spontaneous urticaria: a worldwide perspective.Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Omalizumab for chronic urticaria in Latin America.
@en
Omalizumab for chronic urticaria in Latin America.
@nl
type
label
Omalizumab for chronic urticaria in Latin America.
@en
Omalizumab for chronic urticaria in Latin America.
@nl
prefLabel
Omalizumab for chronic urticaria in Latin America.
@en
Omalizumab for chronic urticaria in Latin America.
@nl
P2093
P2860
P1476
Omalizumab for chronic urticaria in Latin America
@en
P2093
Annia Cherrez
Juan Carlos Calderon
Paola Wilches
Paul Wilches
P2860
P2888
P356
10.1186/S40413-016-0127-Y
P577
2016-11-23T00:00:00Z
P6179
1033492974